Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 25:2022:3206594.
doi: 10.1155/2022/3206594. eCollection 2022.

Causes of Mortality in Korean Patients with Neurodegenerative Dementia

Affiliations

Causes of Mortality in Korean Patients with Neurodegenerative Dementia

Hyo Geun Choi et al. Biomed Res Int. .

Abstract

The prevalence of neurodegenerative dementia is increasing owing to the rapid growth of the older population. We investigated risks and causes of mortality in Korean patients with neurodegenerative dementia using data from the Korean Health Insurance Review and Assessment Service-National Sample Cohort with the aim to improve their care. From a pool of 1,125,691 patients, 11,215 patients aged ≥60 years who were diagnosed with dementia between 2002 and 2013 were examined along with 44,860 matched controls. A Cox proportional hazard model was used to calculate crude and adjusted hazard ratios (HRs). During the follow-up period, 34.5% and 18.8% of individuals in the neurodegenerative dementia and control groups, respectively, died (P < 0.001). The adjusted HR for mortality in the neurodegenerative dementia group was 2.11 (2.41 and 1.96 in men and women, respectively). Moreover, the adjusted HRs in patients with neurodegenerative dementia were 3.25, 2.77, and 1.84 for those diagnosed at ages 60-69, 70-79, and ≥80 years, respectively. The highest odds ratio for mortality was noted among patients with neurologic disease (15.93) followed by those with mental disease (4.89). These data show that the risk of mortality increased regardless of age and sex in Korean patients with neurodegenerative dementia.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest regarding the publication of this article.

Figures

Figure 1
Figure 1
A schematic illustration of the participant selection process that was used in the present study. Of a total of 1,125,691 participants, 13,102 with neurodegenerative dementia were included; these patients were matched 1 : 4 with a control group of individuals not diagnosed with dementia. Ultimately, 11,215 participants with neurodegenerative dementia and 44,860 controls were included.
Figure 2
Figure 2
Kaplan–Meier curves showing mortality rates of Korean patients with dementia versus those of controls over the duration of the study.

Similar articles

Cited by

References

    1. Gale S. A., Acar D., Daffner K. R. Dementia. The American Journal of Medicine . 2018;131(10):1161–1169. doi: 10.1016/j.amjmed.2018.01.022. - DOI - PubMed
    1. Arvanitakis Z., Shah R. C., Bennett D. A. Diagnosis and management of dementia: review. The Journal of American Medical Association . 2019;322(16):1589–1599. doi: 10.1001/jama.2019.4782. - DOI - PMC - PubMed
    1. Nichols E., Szoeke C. E., Vollset S. E., et al. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study. The Lancet Neurology . 2019;18(1):88–106. doi: 10.1016/S1474-4422(18)30403-4. - DOI - PMC - PubMed
    1. Sabat S. R. Dementia in developing countries: a tidal wave on the horizon. The Lancet . 2009;374(9704):1805–1806. doi: 10.1016/S0140-6736(09)62037-7. - DOI - PubMed
    1. Ferri C. P., Prince M., Brayne C., et al. Global prevalence of dementia: a Delphi consensus study. The Lancet . 2005;366(9503):2112–2117. doi: 10.1016/S0140-6736(05)67889-0. - DOI - PMC - PubMed